# Efficacy of Risk Assessment for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy

> **NCT04402268** · — · COMPLETED · sponsor: **Poznan University of Medical Sciences** · enrollment: 252 (actual)

## Conditions studied

- Hypertrophic Cardiomyopathy

## Interventions

- **DEVICE:** Cardioverter-defibrillator

## Key facts

- **NCT ID:** NCT04402268
- **Lead sponsor:** Poznan University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10-01
- **Primary completion:** 2018-09-01
- **Final completion:** 2019-02-28
- **Target enrollment:** 252 (ACTUAL)
- **Last updated:** 2020-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04402268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04402268, "Efficacy of Risk Assessment for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04402268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*